Stock Analysis

Discover 3 US Growth Companies With High Insider Ownership

Published

As the U.S. market navigates a period of uncertainty with stock futures fluctuating ahead of the presidential election and Federal Reserve's interest rate decision, investors are keenly observing how these factors might influence growth trajectories. In such an environment, companies with high insider ownership can be particularly appealing as they often signal strong confidence from those who know the business best, aligning management interests closely with those of shareholders.

Top 10 Growth Companies With High Insider Ownership In The United States

NameInsider OwnershipEarnings Growth
GigaCloud Technology (NasdaqGM:GCT)25.6%26%
Atour Lifestyle Holdings (NasdaqGS:ATAT)26%23.5%
Victory Capital Holdings (NasdaqGS:VCTR)10.2%33.3%
Super Micro Computer (NasdaqGS:SMCI)14.4%25.4%
Hims & Hers Health (NYSE:HIMS)13.7%37.4%
Duolingo (NasdaqGS:DUOL)14.7%41.8%
Credo Technology Group Holding (NasdaqGS:CRDO)13.9%95%
Alkami Technology (NasdaqGS:ALKT)11.2%98.6%
EHang Holdings (NasdaqGM:EH)32.8%81.4%
BBB Foods (NYSE:TBBB)22.9%51.2%

Click here to see the full list of 195 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let's take a closer look at a couple of our picks from the screened companies.

Lindblad Expeditions Holdings (NasdaqCM:LIND)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lindblad Expeditions Holdings, Inc. offers marine expedition adventures and travel experiences globally, with a market cap of $501.02 million.

Operations: The company generates revenue from its marine expedition segment, amounting to $405.86 million, and its land experiences segment, contributing $185.61 million.

Insider Ownership: 32.2%

Lindblad Expeditions Holdings shows potential as a growth company with substantial insider ownership, evidenced by significant insider buying in recent months. Despite reporting a net loss of US$24.67 million for Q2 2024, revenue increased to US$136.5 million from the previous year. The company's revenue is forecasted to grow at 9.5% annually, surpassing the broader U.S. market growth rate of 8.9%. Trading significantly below estimated fair value suggests attractive relative valuation opportunities for investors seeking growth prospects.

NasdaqCM:LIND Earnings and Revenue Growth as at Nov 2024

Enfusion (NYSE:ENFN)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Enfusion, Inc. offers software-as-a-service solutions for the investment management industry across various regions including the United States, Europe, the Middle East, Africa, and the Asia Pacific, with a market cap of approximately $1.16 billion.

Operations: The company's revenue from its online financial information providers segment is $188.35 million.

Insider Ownership: 10.6%

Enfusion demonstrates growth potential with expected earnings growth of 66.6% annually, outpacing the US market's 15.4%. Although insider buying hasn't been substantial recently, the company trades at a significant discount to its estimated fair value. Recent leadership appointments aim to bolster its engineering and client services capabilities as it expands globally. Additionally, Enfusion is exploring strategic options amid acquisition interest, which could impact its future trajectory and valuation dynamics in the investment technology sector.

NYSE:ENFN Earnings and Revenue Growth as at Nov 2024

VTEX (NYSE:VTEX)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: VTEX offers a software-as-a-service digital commerce platform for enterprise brands and retailers, with a market cap of approximately $1.25 billion.

Operations: The company's revenue is primarily derived from its Internet Software & Services segment, totaling $220.54 million.

Insider Ownership: 39.2%

VTEX, with significant insider ownership, has shown strong financial improvement, reporting a net income of US$4.94 million for Q2 2024 compared to a loss last year. The company's earnings are expected to grow significantly at 43.9% annually over the next three years, outpacing the US market average. However, revenue growth is forecasted at 16.4% per year, which is slower than some high-growth benchmarks and impacted by large one-off items affecting earnings quality.

NYSE:VTEX Ownership Breakdown as at Nov 2024

Where To Now?

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're here to simplify it.

Discover if Enfusion might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com